BeaMed

BeaMed: A Private Company Developing Next-Generation Laser Platforms for Epilepsy and Cancer Surgery. BeaMed is the inventor and developer of the StingRay Laser System (“StingRay System”), a novel laser-based thermal ablation technology designed to treat previously inoperable epilepsy cases and improve outcomes in tumor surgeries, enabling new treatment options for brain cancer, prostate cancer, liver cancer, breast cancer, and lung cancer. The StingRay Laser System will utilize the MANTA series of lasers as its core energy-generating device, combined with advanced fiber optic technology, to achieve precise structural targeting and energy delivery to tumors and epileptic foci while protecting critical functional areas from thermal damage.